| 0 |
MENINGITIS CANDIDA |
3 |
0.0429 |
| 1 |
ACRAL LENTIGINOUS MELANOMA |
1 |
0.0238 |
| 2 |
ELECTROCARDIOGRAM J WAVE |
1 |
0.0217 |
| 3 |
HEPATIC INFECTION FUNGAL |
2 |
0.0167 |
| 4 |
PROCALCITONIN DECREASED |
1 |
0.0143 |
| 5 |
BLOOD PRESSURE SYSTOLIC |
1 |
0.0135 |
| 6 |
PITUITARY TUMOUR REMOVAL |
1 |
0.0105 |
| 7 |
ORAL LICHENOID REACTION |
1 |
0.0092 |
| 8 |
VULVAR DYSPLASIA |
1 |
0.0084 |
| 9 |
PENILE DISCOMFORT |
1 |
0.0078 |
| 10 |
COCHLEA IMPLANT |
1 |
0.0073 |
| 11 |
BREAST ULCERATION |
1 |
0.0072 |
| 12 |
CONJUNCTIVAL PALLOR |
1 |
0.0055 |
| 13 |
MALIGNANT MELANOMA STAGE III |
1 |
0.0049 |
| 14 |
FAILURE TO SUSPEND MEDICATION |
1 |
0.0048 |
| 15 |
PENILE BLISTER |
1 |
0.0047 |
| 16 |
TRANSFUSION-RELATED CIRCULATORY OVERLOAD |
1 |
0.0041 |
| 17 |
TYMPANIC MEMBRANE DISORDER |
1 |
0.0031 |
| 18 |
ALLERGIC RESPIRATORY SYMPTOM |
1 |
0.0030 |
| 19 |
KERATOACANTHOMA |
2 |
0.0029 |
| 20 |
PHYSICAL DECONDITIONING |
7 |
0.0027 |
| 21 |
PROTEIN URINE |
2 |
0.0022 |
| 22 |
PATIENT UNCOOPERATIVE |
1 |
0.0021 |
| 23 |
BLOOD IRON ABNORMAL |
2 |
0.0020 |
| 24 |
COMPLICATIONS OF TRANSPLANT SURGERY |
1 |
0.0020 |
| 25 |
ARTERIOVENOUS FISTULA SITE COMPLICATION |
1 |
0.0017 |
| 26 |
URETERIC STENOSIS |
1 |
0.0012 |
| 27 |
SEBORRHOEIC DERMATITIS |
2 |
0.0012 |
| 28 |
ELECTROCARDIOGRAM CHANGE |
1 |
0.0011 |
| 29 |
FOREIGN BODY IN EYE |
1 |
0.0010 |
| 30 |
RED BLOOD CELLS URINE POSITIVE |
1 |
0.0010 |
| 31 |
MAJOR DEPRESSION |
7 |
0.0010 |
| 32 |
KIDNEY ENLARGEMENT |
1 |
0.0009 |
| 33 |
GASTROINTESTINAL TRACT IRRITATION |
1 |
0.0009 |
| 34 |
PRURITUS ALLERGIC |
1 |
0.0009 |
| 35 |
INCISION SITE PAIN |
1 |
0.0009 |
| 36 |
HAEMATOMA MUSCLE |
1 |
0.0008 |
| 37 |
IMMUNE-MEDIATED MYOSITIS |
2 |
0.0007 |
| 38 |
PERIPHERAL ARTERY OCCLUSION |
1 |
0.0007 |
| 39 |
INCORRECT DRUG ADMINISTRATION RATE |
3 |
0.0007 |
| 40 |
PRECANCEROUS CELLS PRESENT |
1 |
0.0007 |
| 41 |
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL |
1 |
0.0007 |
| 42 |
PRECANCEROUS SKIN LESION |
1 |
0.0007 |
| 43 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
1 |
0.0007 |
| 44 |
INTERCEPTED MEDICATION ERROR |
3 |
0.0006 |
| 45 |
IMMUNE-MEDIATED MYOCARDITIS |
1 |
0.0006 |
| 46 |
TERMINAL INSOMNIA |
1 |
0.0006 |
| 47 |
SUSPECTED PRODUCT QUALITY ISSUE |
1 |
0.0005 |
| 48 |
ADENOCARCINOMA OF COLON |
1 |
0.0005 |
| 49 |
OSTEOPOROTIC FRACTURE |
1 |
0.0005 |
| 50 |
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
2 |
0.0005 |
| 51 |
ALANINE AMINOTRANSFERASE ABNORMAL |
1 |
0.0005 |
| 52 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
1 |
0.0004 |
| 53 |
READING DISORDER |
1 |
0.0004 |
| 54 |
PRURITUS GENITAL |
1 |
0.0004 |
| 55 |
WEIGHT ABNORMAL |
1 |
0.0004 |
| 56 |
SEROTONIN SYNDROME |
8 |
0.0004 |
| 57 |
CATHETER SITE HAEMORRHAGE |
1 |
0.0004 |
| 58 |
NASAL DISORDER |
1 |
0.0004 |
| 59 |
NECK INJURY |
1 |
0.0003 |
| 60 |
BLOOD PRESSURE INADEQUATELY CONTROLLED |
2 |
0.0003 |
| 61 |
CEREBROVASCULAR DISORDER |
1 |
0.0003 |
| 62 |
VULVOVAGINAL DRYNESS |
1 |
0.0003 |
| 63 |
POSTURE ABNORMAL |
1 |
0.0003 |
| 64 |
INJECTION SITE INFECTION |
1 |
0.0003 |
| 65 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
1 |
0.0003 |
| 66 |
BK VIRUS INFECTION |
1 |
0.0003 |
| 67 |
LUNG TRANSPLANT |
1 |
0.0003 |
| 68 |
VENOUS THROMBOSIS |
1 |
0.0003 |
| 69 |
BLEPHARITIS |
1 |
0.0002 |
| 70 |
EUGLYCAEMIC DIABETIC KETOACIDOSIS |
1 |
0.0002 |
| 71 |
METASTATIC NEOPLASM |
1 |
0.0002 |
| 72 |
PLATELET COUNT INCREASED |
3 |
0.0002 |
| 73 |
MELANOCYTIC NAEVUS |
1 |
0.0002 |
| 74 |
TUMOUR LYSIS SYNDROME |
2 |
0.0002 |
| 75 |
WHEELCHAIR USER |
1 |
0.0002 |
| 76 |
URINE ABNORMALITY |
1 |
0.0002 |
| 77 |
METABOLIC ACIDOSIS |
7 |
0.0002 |
| 78 |
ISCHAEMIA |
1 |
0.0002 |
| 79 |
LIMB OPERATION |
1 |
0.0002 |
| 80 |
SINUS BRADYCARDIA |
2 |
0.0002 |
| 81 |
FOOT OPERATION |
1 |
0.0002 |
| 82 |
GASTROINTESTINAL SOUNDS ABNORMAL |
1 |
0.0002 |
| 83 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 84 |
FLUID INTAKE REDUCED |
1 |
0.0002 |
| 85 |
CORONARY ARTERY STENOSIS |
1 |
0.0002 |
| 86 |
COLORECTAL CANCER STAGE III |
1 |
0.0002 |
| 87 |
DRUG TOLERANCE |
1 |
0.0002 |
| 88 |
POLYARTHRITIS |
1 |
0.0002 |
| 89 |
HYPERTENSIVE CRISIS |
2 |
0.0002 |
| 90 |
HERPES VIRUS INFECTION |
1 |
0.0002 |
| 91 |
BLOOD URIC ACID INCREASED |
1 |
0.0002 |
| 92 |
MADAROSIS |
2 |
0.0002 |
| 93 |
SUICIDE ATTEMPT |
10 |
0.0002 |
| 94 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
0.0002 |
| 95 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 96 |
SWELLING OF EYELID |
1 |
0.0002 |
| 97 |
BLOOD SODIUM DECREASED |
3 |
0.0002 |
| 98 |
PHOTOPSIA |
1 |
0.0002 |
| 99 |
PROCTALGIA |
1 |
0.0002 |
| 100 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 101 |
APPETITE DISORDER |
1 |
0.0002 |
| 102 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 103 |
ABNORMAL LOSS OF WEIGHT |
1 |
0.0001 |
| 104 |
EXTRASYSTOLES |
1 |
0.0001 |
| 105 |
INTENTIONAL OVERDOSE |
9 |
0.0001 |
| 106 |
HYDRONEPHROSIS |
1 |
0.0001 |
| 107 |
PAROSMIA |
1 |
0.0001 |
| 108 |
BRONCHOPULMONARY ASPERGILLOSIS |
1 |
0.0001 |
| 109 |
BASAL CELL CARCINOMA |
2 |
0.0001 |
| 110 |
GASTROINTESTINAL INFLAMMATION |
1 |
0.0001 |
| 111 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 112 |
ARTERIAL OCCLUSIVE DISEASE |
1 |
0.0001 |
| 113 |
FURUNCLE |
1 |
0.0001 |
| 114 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 115 |
UTERINE CANCER |
1 |
0.0001 |
| 116 |
MUSCLE DISORDER |
1 |
0.0001 |
| 117 |
BLOOD POTASSIUM INCREASED |
2 |
0.0001 |
| 118 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 119 |
HAIR DISORDER |
1 |
0.0001 |
| 120 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 121 |
ANURIA |
1 |
0.0001 |
| 122 |
PSYCHOLOGICAL TRAUMA |
1 |
0.0001 |
| 123 |
MYOPATHY |
1 |
0.0001 |
| 124 |
MUSCLE STRAIN |
1 |
0.0001 |
| 125 |
SKIN SWELLING |
1 |
0.0001 |
| 126 |
FACIAL PAIN |
1 |
0.0001 |
| 127 |
THIRST |
2 |
0.0001 |
| 128 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 129 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 130 |
POISONING DELIBERATE |
1 |
0.0001 |
| 131 |
PROTEINURIA |
2 |
0.0001 |
| 132 |
EYE INFLAMMATION |
1 |
0.0001 |
| 133 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 134 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 135 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 136 |
HYPOTONIA |
1 |
0.0001 |
| 137 |
OVARIAN CYST |
1 |
0.0001 |
| 138 |
POOR QUALITY DEVICE USED |
1 |
0.0001 |
| 139 |
HYPOTHERMIA |
1 |
0.0001 |
| 140 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 141 |
POLLAKIURIA |
4 |
0.0001 |
| 142 |
CARDIO-RESPIRATORY ARREST |
4 |
0.0001 |
| 143 |
PRODUCT ODOUR ABNORMAL |
1 |
0.0001 |
| 144 |
MOUTH ULCERATION |
2 |
0.0001 |
| 145 |
FISTULA |
1 |
0.0001 |
| 146 |
EYELID OEDEMA |
1 |
0.0001 |
| 147 |
SEXUAL DYSFUNCTION |
1 |
0.0001 |
| 148 |
NOCTURIA |
1 |
0.0001 |
| 149 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 150 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 151 |
HEPATIC CYTOLYSIS |
1 |
0.0001 |
| 152 |
ANHEDONIA |
2 |
0.0001 |
| 153 |
BEDRIDDEN |
1 |
0.0001 |
| 154 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
| 155 |
MALIGNANT MELANOMA |
1 |
0.0001 |
| 156 |
EXTRA DOSE ADMINISTERED |
3 |
0.0001 |
| 157 |
PRODUCT TASTE ABNORMAL |
1 |
0.0001 |
| 158 |
ACUTE HEPATIC FAILURE |
1 |
0.0001 |
| 159 |
FEELING COLD |
2 |
0.0001 |
| 160 |
DEMENTIA |
2 |
0.0001 |
| 161 |
HEPATOCELLULAR INJURY |
1 |
0.0001 |
| 162 |
ACCIDENTAL UNDERDOSE |
1 |
0.0001 |
| 163 |
PRODUCT SUBSTITUTION ISSUE |
4 |
0.0001 |
| 164 |
SEPTIC SHOCK |
3 |
0.0001 |
| 165 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 166 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 167 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 168 |
DELUSION |
1 |
0.0001 |
| 169 |
LUNG INFECTION |
1 |
0.0001 |
| 170 |
BLOOD CHOLESTEROL INCREASED |
3 |
0.0001 |
| 171 |
DRUG-INDUCED LIVER INJURY |
2 |
0.0001 |
| 172 |
ARTHRITIS |
5 |
0.0001 |
| 173 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 174 |
HALLUCINATION, AUDITORY |
1 |
0.0001 |
| 175 |
HYPOTHYROIDISM |
2 |
0.0001 |
| 176 |
URINARY RETENTION |
2 |
0.0001 |
| 177 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 178 |
GASTRIC DISORDER |
2 |
0.0001 |
| 179 |
RASH MACULAR |
2 |
0.0001 |
| 180 |
HYPERKALAEMIA |
2 |
0.0001 |
| 181 |
HEART RATE DECREASED |
2 |
0.0001 |
| 182 |
COLD SWEAT |
1 |
0.0001 |
| 183 |
DRUG INTERACTION |
9 |
0.0001 |
| 184 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 185 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 186 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 187 |
DRUG ERUPTION |
1 |
0.0001 |
| 188 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 189 |
TOOTHACHE |
1 |
0.0001 |
| 190 |
C-REACTIVE PROTEIN INCREASED |
2 |
0.0001 |
| 191 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 192 |
RESTLESSNESS |
2 |
0.0001 |
| 193 |
BLOOD GLUCOSE ABNORMAL |
1 |
0.0001 |
| 194 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 195 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 196 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 197 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 198 |
FLATULENCE |
3 |
0.0001 |
| 199 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 200 |
INCREASED APPETITE |
1 |
0.0001 |
| 201 |
CHOLESTASIS |
1 |
0.0001 |
| 202 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 203 |
HERNIA |
1 |
0.0001 |
| 204 |
HAEMORRHOIDS |
1 |
0.0001 |
| 205 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 206 |
SPINAL FRACTURE |
1 |
0.0000 |
| 207 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 208 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 209 |
FEEDING DISORDER |
1 |
0.0000 |
| 210 |
OSTEOPOROSIS |
2 |
0.0000 |
| 211 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 212 |
ANAEMIA |
9 |
0.0000 |
| 213 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 214 |
ACUTE KIDNEY INJURY |
7 |
0.0000 |
| 215 |
HEPATOTOXICITY |
1 |
0.0000 |
| 216 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 217 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 218 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
8 |
0.0000 |
| 219 |
CHROMATURIA |
1 |
0.0000 |
| 220 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 221 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 222 |
HYPERTENSION |
9 |
0.0000 |
| 223 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
3 |
0.0000 |
| 224 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 225 |
BLOOD GLUCOSE DECREASED |
2 |
0.0000 |
| 226 |
HEPATIC CANCER |
1 |
0.0000 |
| 227 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 228 |
FIBROMYALGIA |
1 |
0.0000 |
| 229 |
AGEUSIA |
1 |
0.0000 |
| 230 |
DIABETES MELLITUS |
3 |
0.0000 |
| 231 |
HYPOPHAGIA |
1 |
0.0000 |
| 232 |
ERECTILE DYSFUNCTION |
1 |
0.0000 |
| 233 |
SKIN ULCER |
1 |
0.0000 |
| 234 |
HAEMATOMA |
1 |
0.0000 |
| 235 |
DEAFNESS |
1 |
0.0000 |
| 236 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 237 |
GASTRITIS |
1 |
0.0000 |
| 238 |
CARDIAC FAILURE |
3 |
0.0000 |
| 239 |
SKIN LESION |
1 |
0.0000 |
| 240 |
PRODUCT USE IN UNAPPROVED INDICATION |
9 |
0.0000 |
| 241 |
SEPSIS |
4 |
0.0000 |
| 242 |
HAEMOPTYSIS |
1 |
0.0000 |
| 243 |
PANCYTOPENIA |
2 |
0.0000 |
| 244 |
WOUND |
1 |
0.0000 |
| 245 |
RENAL IMPAIRMENT |
3 |
0.0000 |
| 246 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 247 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 248 |
ANGINA PECTORIS |
1 |
0.0000 |
| 249 |
BALANCE DISORDER |
3 |
0.0000 |
| 250 |
DYSSTASIA |
1 |
0.0000 |
| 251 |
ERYTHEMA |
7 |
0.0000 |
| 252 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 253 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 254 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 255 |
APHASIA |
1 |
0.0000 |
| 256 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 257 |
EPILEPSY |
1 |
0.0000 |
| 258 |
ADVERSE EVENT |
3 |
0.0000 |
| 259 |
WEIGHT DECREASED |
9 |
0.0000 |
| 260 |
SWELLING |
3 |
0.0000 |
| 261 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 262 |
PULMONARY EMBOLISM |
3 |
0.0000 |
| 263 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 264 |
NIGHT SWEATS |
1 |
0.0000 |
| 265 |
ATRIAL FIBRILLATION |
3 |
0.0000 |
| 266 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 267 |
FEBRILE NEUTROPENIA |
2 |
0.0000 |
| 268 |
FUNGAL INFECTION |
1 |
0.0000 |
| 269 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 270 |
GAIT INABILITY |
1 |
0.0000 |
| 271 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 272 |
URINARY TRACT INFECTION |
5 |
0.0000 |
| 273 |
ILLNESS |
3 |
0.0000 |
| 274 |
DELIRIUM |
1 |
0.0000 |
| 275 |
ABDOMINAL DISTENSION |
3 |
0.0000 |
| 276 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 277 |
MYELOSUPPRESSION |
1 |
0.0000 |
| 278 |
PANIC ATTACK |
1 |
0.0000 |
| 279 |
DYSURIA |
1 |
0.0000 |
| 280 |
INJECTION SITE MASS |
1 |
0.0000 |
| 281 |
EYE SWELLING |
1 |
0.0000 |
| 282 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 283 |
COLITIS |
1 |
0.0000 |
| 284 |
BLOOD PRESSURE INCREASED |
4 |
0.0000 |
| 285 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 286 |
PYREXIA |
9 |
0.0000 |
| 287 |
PERIPHERAL SWELLING |
4 |
0.0000 |
| 288 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 289 |
DISORIENTATION |
1 |
0.0000 |
| 290 |
THROMBOSIS |
2 |
0.0000 |
| 291 |
EMOTIONAL DISTRESS |
3 |
0.0000 |
| 292 |
DRY MOUTH |
2 |
0.0000 |
| 293 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 294 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 295 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 296 |
CEREBROVASCULAR ACCIDENT |
4 |
0.0000 |
| 297 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 298 |
MYOCARDIAL INFARCTION |
4 |
0.0000 |
| 299 |
CONSTIPATION |
5 |
0.0000 |
| 300 |
INSOMNIA |
6 |
0.0000 |
| 301 |
MATERNAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 302 |
THROAT IRRITATION |
1 |
0.0000 |
| 303 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 304 |
TINNITUS |
1 |
0.0000 |
| 305 |
HYPOKALAEMIA |
1 |
0.0000 |
| 306 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 307 |
BLOOD GLUCOSE INCREASED |
4 |
0.0000 |
| 308 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 309 |
COMA |
1 |
0.0000 |
| 310 |
MIGRAINE |
2 |
0.0000 |
| 311 |
COLORECTAL CANCER |
1 |
0.0000 |
| 312 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 313 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 314 |
ALOPECIA |
4 |
0.0000 |
| 315 |
PAIN IN EXTREMITY |
6 |
0.0000 |
| 316 |
DRY EYE |
1 |
0.0000 |
| 317 |
LEUKOPENIA |
1 |
0.0000 |
| 318 |
AGGRESSION |
1 |
0.0000 |
| 319 |
SOMNOLENCE |
4 |
0.0000 |
| 320 |
CONDITION AGGRAVATED |
6 |
0.0000 |
| 321 |
PAIN |
12 |
0.0000 |
| 322 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 323 |
NERVOUSNESS |
1 |
0.0000 |
| 324 |
DEPRESSED MOOD |
1 |
0.0000 |
| 325 |
BRADYCARDIA |
1 |
0.0000 |
| 326 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 327 |
ASTHENIA |
7 |
0.0000 |
| 328 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 329 |
CONFUSIONAL STATE |
3 |
0.0000 |
| 330 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 331 |
PNEUMONIA |
6 |
0.0000 |
| 332 |
PRURITUS |
7 |
0.0000 |
| 333 |
TREMOR |
3 |
0.0000 |
| 334 |
ARTHROPATHY |
1 |
0.0000 |
| 335 |
INFLUENZA |
2 |
0.0000 |
| 336 |
URTICARIA |
3 |
0.0000 |
| 337 |
NECK PAIN |
1 |
0.0000 |
| 338 |
COUGH |
5 |
0.0000 |
| 339 |
EYE PAIN |
1 |
0.0000 |
| 340 |
ASTHMA |
2 |
0.0000 |
| 341 |
ANXIETY |
5 |
0.0000 |
| 342 |
SEIZURE |
2 |
0.0000 |
| 343 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 344 |
CHILLS |
2 |
0.0000 |
| 345 |
BLADDER CANCER |
1 |
0.0000 |
| 346 |
FEELING ABNORMAL |
4 |
0.0000 |
| 347 |
IRRITABILITY |
1 |
0.0000 |
| 348 |
JOINT SWELLING |
2 |
0.0000 |
| 349 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 350 |
VERTIGO |
1 |
0.0000 |
| 351 |
DISCOMFORT |
1 |
0.0000 |
| 352 |
MUSCLE SPASMS |
3 |
0.0000 |
| 353 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 354 |
CHEST PAIN |
3 |
0.0000 |
| 355 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 356 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 357 |
MALAISE |
7 |
0.0000 |
| 358 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 359 |
AMNESIA |
1 |
0.0000 |
| 360 |
PSORIASIS |
2 |
0.0000 |
| 361 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 362 |
HYPOTENSION |
3 |
0.0000 |
| 363 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 364 |
NEUTROPENIA |
2 |
0.0000 |
| 365 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 366 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 367 |
SLEEP DISORDER |
1 |
0.0000 |
| 368 |
DIZZINESS |
7 |
0.0000 |
| 369 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 370 |
MOBILITY DECREASED |
1 |
0.0000 |
| 371 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 372 |
AGITATION |
1 |
0.0000 |
| 373 |
EPISTAXIS |
1 |
0.0000 |
| 374 |
HYPOAESTHESIA |
2 |
0.0000 |
| 375 |
HOT FLUSH |
1 |
0.0000 |
| 376 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 377 |
DECREASED APPETITE |
3 |
0.0000 |
| 378 |
BACK PAIN |
3 |
0.0000 |
| 379 |
ABDOMINAL PAIN |
3 |
0.0000 |
| 380 |
DRUG DOSE OMISSION BY DEVICE |
1 |
0.0000 |
| 381 |
OFF LABEL USE |
11 |
0.0000 |
| 382 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 383 |
PROSTATE CANCER |
1 |
0.0000 |
| 384 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 385 |
DYSPNOEA |
7 |
0.0000 |
| 386 |
CARDIAC ARREST |
1 |
0.0000 |
| 387 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 388 |
RASH |
5 |
0.0000 |
| 389 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 390 |
COVID-19 |
2 |
0.0000 |
| 391 |
DRUG WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 392 |
TACHYCARDIA |
1 |
0.0000 |
| 393 |
HEADACHE |
7 |
0.0000 |
| 394 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 395 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 396 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 397 |
CARDIAC DISORDER |
1 |
0.0000 |
| 398 |
DYSPHAGIA |
1 |
0.0000 |
| 399 |
DYSPEPSIA |
1 |
0.0000 |
| 400 |
HEART RATE INCREASED |
1 |
0.0000 |
| 401 |
SYNCOPE |
1 |
0.0000 |
| 402 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 403 |
FLUSHING |
1 |
0.0000 |
| 404 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 405 |
ARTHRALGIA |
4 |
0.0000 |
| 406 |
HAEMORRHAGE |
1 |
0.0000 |
| 407 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 408 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 409 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 410 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 411 |
PALPITATIONS |
1 |
0.0000 |
| 412 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 413 |
DRUG INEFFECTIVE |
11 |
0.0000 |
| 414 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 415 |
HYPERHIDROSIS |
1 |
0.0000 |
| 416 |
RENAL FAILURE |
1 |
0.0000 |
| 417 |
DEHYDRATION |
1 |
0.0000 |
| 418 |
DRY SKIN |
1 |
0.0000 |
| 419 |
VISION BLURRED |
1 |
0.0000 |
| 420 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 421 |
HOSPITALISATION |
1 |
0.0000 |
| 422 |
FATIGUE |
5 |
0.0000 |
| 423 |
VOMITING |
3 |
0.0000 |
| 424 |
NAUSEA |
5 |
0.0000 |
| 425 |
DIARRHOEA |
4 |
0.0000 |
| 426 |
FALL |
2 |
0.0000 |
| 427 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 428 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 429 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 430 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 431 |
DEATH |
4 |
0.0000 |
| 432 |
OVERDOSE |
1 |
0.0000 |
| 433 |
WEIGHT INCREASED |
1 |
0.0000 |
| 434 |
DEPRESSION |
1 |
0.0000 |
| 435 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |